Compare Diageo plc (DEO) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diageo plc vs Immunovant Inc. Common Stock — how do they compare? Diageo plc trades at $86.52 (market cap $47.67B), while Immunovant Inc. Common Stock trades at $30.56 (market cap $6.25B). The key difference: Diageo plc is far larger — about 7.6× Immunovant Inc. Common Stock's market cap, and Diageo plc pays a 2.3% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Diageo plc for 66 Days and Immunovant Inc. Common Stock for 0 Days on average.
| DEO | IMVT | |
|---|---|---|
Market Cap | $47.67B | $6.25B |
Volume | 893,372 | 1,755,411 |
Sector | Consumer Staples | Health |
52-Week High | $102.14 | $44.96 |
52-Week Low | $72.47 | $17.03 |
Typical Hold Time | 66 Days | 0 Days |
Enterprise Value | $68.09B | $5.35B |
Dividend Yield | 2.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diageo (DEO) trades at $86.82, up 2.47% with bullish technical signals and strong analyst support. The stock shows solid fundamentals with consistent earnings beats, a 15.82% ROE, and improving cash flow trends. Recent corporate developments include a new CFO appointment and marketing initiatives supporting brand strength amid ongoing US business restructuring.
The outlook remains positive with 49% analyst buy ratings and cost-saving initiatives driving margin improvement. Key risks include US market volatility and regulatory challenges in India. The stock presents a compelling turnaround story with valuation support at current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
